Venetoclax and Azacitidine for Newly Diagnosed Non-Elderly Adult Patients with Acute Myeloid Leukemia and Adverse Risk Features

被引：7
|
作者：
Gutman, Jonathan A.
Winters, Amanda
Amaya, Maria L.
McMahon, Christine M.
Schowinsky, Jeffrey
Abbott, Diana
Hammes, Andrew
Pei, Shanshan
Stevens, Brett M.
Jordan, Craig T.
Smith, Clayton
Pollyea, Daniel A.
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-136120
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Azacitidine in a patient with newly diagnosed acute myeloid leukemia and poor risk cytogenetics: Outcomes of prolonged therapy
    Pappa, Vasiliki
    Girkas, Konstantinos
    Sambani, Constantina
    Pagageorgiou, Sotiris
    Tsirigiotis, Panagiotis
    Karvounis, Kiki
    Stathopoulou, Evangelia
    Economopoulos, Theofanis
    Dimitriadis, George
    Dervenoulas, Ioannis
    LEUKEMIA RESEARCH, 2012, 36 (04) : E78 - E80
  • [42] A Successful Bridge Therapy Combining Hypomethylating Agents with Venetoclax for Adult Patients with Newly Diagnosed or Relapsed/Refractory Acute Myeloid Leukemia
    Bang, Su-Yeon
    Park, Silvia
    Kwag, Daehun
    Lee, Jong Hyuk
    Min, Gi-June
    Park, Sung-Soo
    Yoon, Jae-Ho
    Lee, Sung-Eun
    Cho, Byung-Sik
    Eom, Ki-Seong
    Kim, Yoo-Jin
    Lee, Seok
    Min, Chang-Ki
    Cho, Seok-Goo
    Lee, Jong Wook
    Kim, Hee-Je
    CANCERS, 2023, 15 (06)
  • [43] Outcomes of Adult Patients with Newly Diagnosed IDH-Mutated Acute Myeloid Leukemia Receiving Intensive Chemotherapy Plus Venetoclax
    Croden, Jennifer
    Marvin-Peek, Jennifer
    Konopleva, Marina
    Borthakur, Gautam
    Daver, Naval
    Abbas, Hussein A.
    Takahashi, Koichi
    Sasaki, Koji
    Garcia-Manero, Guillermo
    Jain, Nitin
    Pemmaraju, Naveen
    Short, Nicholas J.
    Hammond, Danielle
    Jabbour, Elias
    Masarova, Lucia
    Chien, Kelly S.
    Issa, Ghayas C.
    Montalban-Bravo, Guillermo
    Yilmaz, Musa
    Maiti, Abhishek
    Valero, Yesid Alvarado
    Kornblau, Steven M.
    Ravandi, Farhad
    Kantarjian, Hagop
    Kadia, Tapan M.
    Dinardo, Courtney D.
    BLOOD, 2024, 144 : 6126 - 6128
  • [44] Incidence and Risk Factors for Development of Cardiac Toxicity in Adult Patients with Newly Diagnosed Acute Myeloid Leukemia
    Boluda, Blanca
    Solana-Altabella, Antonio
    Cano, Isabel
    Martinez-Cuadron, David
    Acuna-Cruz, Evelyn
    Torres-Minana, Laura
    Rodriguez-Veiga, Rebeca
    Navarro-Vicente, Irene
    Martinez-Campuzano, David
    Garcia-Ruiz, Raquel
    Lloret, Pilar
    Asensi, Pedro
    Osa-Saez, Ana
    Aguero, Jaume
    Rodriguez-Serrano, Maria
    Buendia-Fuentes, Francisco
    Megias-Vericat, Juan Eduardo
    Martin-Herreros, Beatriz
    Barragan, Eva
    Sargas, Claudia
    Salas, Maribel
    Wooddell, Margaret
    Dharmani, Charles
    Sanz, Miguel A.
    De la Rubia, Javier
    Montesinos, Pau
    CANCERS, 2023, 15 (08)
  • [45] Azacitidine in combination with shortened venetoclax treatment cycles in patients with acute myeloid leukemia
    Fleischmann, Maximilian
    Jentzsch, Madlen
    Brioli, Annamaria
    Eisele, Florian
    Frietsch, Jochen J.
    Eigendorff, Farina
    Tober, Romy
    Schrenk, Karin G.
    Hammersen, Jakob Friedrich
    Yomade, Olaposi
    Hilgendorf, Inken
    Hochhaus, Andreas
    Scholl, Sebastian
    Schnetzke, Ulf
    ANNALS OF HEMATOLOGY, 2025, 104 (01) : 285 - 294
  • [46] Venetoclax and azacitidine therapy in acute myeloid leukemia patients with severe renal impairment
    Naka, Ryosuke
    Kondo, Tadakazu
    Nishikubo, Masashi
    Muranushi, Hiroyuki
    Ueda, Yasunori
    Oka, Tomomi
    Wada, Fumiya
    Kanda, Junya
    Yamamoto, Shohei
    Watanabe, Mitsumasa
    Okada, Shinri
    Imada, Kazunori
    Nakabo, Yukiharu
    Mizutani, Yu
    Nannya, Yasuhito
    Ogawa, Seishi
    Ishikawa, Takayuki
    AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 (09) : E251 - E254
  • [47] Oral azacitidine plus venetoclax in patients with relapsed/refractory or newly diagnosed acute myeloid leukemia: The phase 1b OMNIVERSE trial.
    Ravandi, Farhad
    Carraway, Hetty E.
    Taningco, Lilia
    Laille, Eric
    Gong, Jing
    Prebet, Thomas
    De Menezes, Daniel Lopes
    Wei, Andrew H.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [48] Updated Safety and Efficacy of Venetoclax with Decitabine or Azacitidine in Treatment-Naive, Elderly Patients with Acute Myeloid Leukemia
    DiNardo, Courtney D.
    Pollyea, Daniel A.
    Jonas, Brian A.
    Konopleva, Marina
    Pullarkat, Vinod
    Wei, Andrew
    Kantarjian, Hagop M.
    Pigneux, Arnaud
    Recher, Christian
    Seymour, John F.
    Dunbar, Martin
    Xu, Tu
    Mabry, Mack
    Potluri, Jalaja
    Pratz, Keith
    Letai, Anthony
    BLOOD, 2017, 130
  • [49] Venetoclax with azacitidine for two younger Jehovah's Witness patients with high risk acute myeloid leukemia
    Bock, Allison M.
    Pollyea, Daniel A.
    AMERICAN JOURNAL OF HEMATOLOGY, 2020, 95 (10) : E269 - E272
  • [50] Retinal abnormalities in newly diagnosed adult acute myeloid leukemia
    Specchia, G
    Albano, F
    Guerriero, S
    Buquicchio, C
    Pomes, L
    Pastore, D
    Carluccio, P
    Delle Noci, N
    Liso, V
    ACTA HAEMATOLOGICA, 2001, 105 (04) : 197 - 203
12345